{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T18:26:03Z","timestamp":1787336763999,"version":"build-2736575974"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Peak-Shaping Project under Guangzhou University of Chinese Medicine\u2019s Action Plan for Double First-Class and High-Level Disciplinary Development","award":["GZY2025ZJ18"],"award-info":[{"award-number":["GZY2025ZJ18"]}]},{"name":"Guangdong Provincial Higher Education Innovation Team Project","award":["2025KCXTD011"],"award-info":[{"award-number":["2025KCXTD011"]}]},{"name":"Shenzhen Medical Research Fund","award":["C2501027"],"award-info":[{"award-number":["C2501027"]}]},{"name":"Research and Practice on Optimization Strategies for a Clinical Recommendation System for Non-Pharmacological Interventions in Substance Use Disorders Driven by Large Language Models","award":["A3-0317-25-109-009"],"award-info":[{"award-number":["A3-0317-25-109-009"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Background<\/jats:title>\n Cannabis use disorder (CUD) imposes a significant global health burden, yet comparative evidence for the diverse range of non-pharmacological interventions (NPIs) remains fragmented. Existing reviews often combine diverse NPIs into broad categories, overlooking the specific contributions of neurobiological modalities. This study aims to establish a comprehensive comparative efficacy hierarchy for non-pharmacological CUD interventions by integrating psychosocial therapies and neurotherapy into a unified analytical framework.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We will conduct a systematic review and network meta-analysis (NMA) of randomized controlled trials comparing NPIs against control group(including waitlist, no-intervention, or non-specific control) or another NPIs for individuals with CUD. Systematic searches will be performed across PubMed, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), and the Cumulative Index to Nursing and Allied Health Literature (CINAHL). Primary benefit outcomes will include biochemically verified cannabis abstinenc and self-reported days of cannabis use over the past 30 days. Primary acceptability will be evaluated by treatment retention, defined using an intention-to-treat approach as the proportion of randomized participants completing at least one session during the final treatment week, alongside follow-up retention rates. Primary safety will be assessed by the overall incidence of intervention-related adverse and serious adverse events. Pairs of reviewers will independently perform study selection, data extraction, and risk of bias. A frequentist NMA will be conducted to synthesize evidence. We will employ the Grading of Recommendations Assessment, Development and Evaluations(GRADE) approach to assess the certainty of evidence and categorize interventions using a minimally contextualized framework based on predefined decision thresholds.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Comprehensive search strategies have been validated across target databases. Formal study screening, data extraction, quantitative network meta-analyses, and GRADE evidence assessments are scheduled for completion by September 2026, followed by final manuscript preparation.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n This NMA will establish a comprehensive comparative evidence hierarchy for non-pharmacological CUD interventions by bridging psychosocial and neurobiological modalities. By pairing network estimates with GRADE certainty assessments, our findings will offer a standardized, actionable foundation for tailored clinical care and future trial methodology.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n \n PROSPERO\n CRD420251173215<\/jats:ext-link>\n .\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0355941","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:29:36Z","timestamp":1787333376000},"page":"e0355941","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of non-pharmacological interventions for individuals with cannabis use disorder: a systematic review and network meta-analysis protocol"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-3165","authenticated-orcid":true,"given":"Miaomiao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingcong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7821-4699","authenticated-orcid":true,"given":"Liming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"2","key":"pone.0355941.ref001","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41591-025-04137-0","article-title":"Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990-2023: a global burden of disease study","volume":"32","author":"J Kang","year":"2026","journal-title":"Nat Med"},{"issue":"20","key":"pone.0355941.ref002","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172887","article-title":"Cannabis use disorder: from neurobiology to treatment","volume":"134","author":"B Le Foll","year":"2024","journal-title":"J Clin Invest"},{"key":"pone.0355941.ref003","doi-asserted-by":"crossref","first-page":"173","DOI":"10.12688\/f1000research.11191.1","article-title":"Psychosocial and pharmacological interventions for the treatment of cannabis use disorder","volume":"7","author":"P Sabioni","year":"2018","journal-title":"F1000Res"},{"issue":"5","key":"pone.0355941.ref004","article-title":"Psychosocial interventions for cannabis use disorder","volume":"2016","author":"PJ Gates","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"pone.0355941.ref005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.psc.2010.04.012","article-title":"Cognitive behavioral therapy for substance use disorders","volume":"33","author":"RK McHugh","year":"2010","journal-title":"Psychiatr Clin North Am"},{"issue":"1","key":"pone.0355941.ref006","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/brainsci13010036","article-title":"Contingency management for treatment of cannabis use disorder in co-occurring mental health disorders: a systematic review","volume":"13","author":"JD Rodas","year":"2022","journal-title":"Brain Sci"},{"issue":"4","key":"pone.0355941.ref007","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic Advances from the Brain Disease Model of Addiction","volume":"374","author":"ND Volkow","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0355941.ref008","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/npp.2017.212","article-title":"The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal","volume":"43","author":"CA Brezing","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"pone.0355941.ref009","doi-asserted-by":"crossref","first-page":"103295","DOI":"10.1016\/j.drugpo.2021.103295","article-title":"Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis","volume":"97","author":"A Bahji","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"9","key":"pone.0355941.ref010","article-title":"Pharmacotherapies for cannabis use disorder","volume":"9","author":"F Spiga","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0355941.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2016.02.034","article-title":"Acupuncture for substance use disorders: A systematic review and meta-analysis","volume":"163","author":"S Grant","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"pone.0355941.ref012","article-title":"Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta-analysis","author":"M Halicka","year":"2026","journal-title":"Addiction"},{"issue":"11","key":"pone.0355941.ref013","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/add.70084","article-title":"Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta-analysis","volume":"120","author":"M Halicka","year":"2025","journal-title":"Addiction"},{"key":"pone.0355941.ref014","doi-asserted-by":"crossref","first-page":"111321","DOI":"10.1016\/j.drugalcdep.2024.111321","article-title":"Cognitive-behavioral therapies in the management of adolescents with cannabis use disorder (CUD): A systematic review","volume":"260","author":"S Mauries","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"pone.0355941.ref015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"L Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"6","key":"pone.0355941.ref016","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jamapsychiatry.2017.0724","article-title":"US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013","volume":"74","author":"DS Hasin","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"pone.0355941.ref017","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5 (updated January 2024). Cochrane; 2024. Available from: https:\/\/training.cochrane.org\/handbook"},{"issue":"2","key":"pone.0355941.ref018","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.clinph.2019.11.002","article-title":"Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)","volume":"131","author":"J-P Lefaucheur","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"pone.0355941.ref019","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081199","article-title":"Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials","volume":"388","author":"Y Wang","year":"2025","journal-title":"BMJ"},{"key":"pone.0355941.ref020","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"MA Puhan","year":"2014","journal-title":"BMJ"},{"key":"pone.0355941.ref021","article-title":"GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework","volume":"371","author":"R Brignardello-Petersen","year":"2020","journal-title":"BMJ"},{"key":"pone.0355941.ref022","first-page":"107","article-title":"GRADE approach to rate the certainty from a network meta-analysis: addressing decision-making needs\u2014GRADE concept 10","volume":"124","author":"R Brignardello-Petersen","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"pone.0355941.ref023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jclinepi.2021.07.011","article-title":"GRADE approach to rate the certainty in a network meta-analysis: rating imprecision","volume":"139","author":"R Brignardello-Petersen","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"pone.0355941.ref024","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-079971","article-title":"Common interventional procedures for chronic non-cancer spine pain: a systematic review and network meta-analysis of randomised trials","volume":"388","author":"X Wang","year":"2025","journal-title":"BMJ"},{"key":"pone.0355941.ref025","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.drugalcdep.2018.10.020","article-title":"Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder","volume":"194","author":"DC Lee","year":"2019","journal-title":"Drug Alcohol Depend"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:29:41Z","timestamp":1787333381000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355941"}},"subtitle":[],"editor":[{"given":"Alberto Souza","family":"S\u00e1 Filho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0355941","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}